Clinical Trial Update: Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily [Phase 2]

View source ↗

Summary

An exploratory Phase 2 trial comparing D565H twice daily versus D565 once daily for open-angle glaucoma and ocular hypertension. The document does not provide r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• D565
• D565H

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Phase 2 | Status: UNKNOWN